直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Fed. Circ.’s Suprema Ruling Seals ITC Loopholes, Attys Say

August 10, 2015

Law360

In Suprema Inc. et al. v. International Trade Commission, a split Federal Circuit ruled that the ITC has the authority to police induced infringement claims. This closes loopholes and prevents importers from bringing infringing products into the United States. The decision reversed a 2013 precedential ruling, which found that Section 337 of the Tariff Act only covers products that directly infringe U.S. patents at the time of importation. Finnegan attorney Eric J. Fues filed the amicus brief on behalf of the International Trade Commission Trial Lawyers Association. He said that the Federal Circuit's decision settles the question of whether a solution for the indirect infringement of method claims can be pursued at the ITC. He believes that the Federal Circuit's split decision may lead to an appeal at the Supreme Court.

Tags

United States Court of Appeals for the Federal Circuit (CAFC), International Trade Commission (ITC)

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Professionals

Eric J. Fues
Partner
Washington, DC
+1 202 408 4245
Email

Related News

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP